Rongtai Health 荣泰健康
6 significant filings since 1 Jun 2026: 4 on buyback and 2 on dividend. The latest, on 19 Jun 2026: 上海荣泰健康科技股份有限公司关于股份回购实施结果暨股份变动的公告.
自 1 Jun 2026 起有 6 份重大公告：buyback 4 份、dividend 2 份。最新一份（19 Jun 2026）：上海荣泰健康科技股份有限公司关于股份回购实施结果暨股份变动的公告。
Price History 价格走势
1,250 trading days 个交易日 · High 最高 ¥42.10 · Low 最低 ¥10.65The tick on each bar marks the whole market, where 99.3% of rated reports in the same twelve months said Buy or Outperform. 刻度线为全市场水平：同期 99.3% 的评级为买入或跑赢。 Every rated report on this company said Buy or Outperform.
| Date 日期 | Broker 券商 | Analyst 分析师 | From 原评级 | To 新评级 | |
|---|---|---|---|---|---|
| 23 Apr 2023 | 西南证券 | 龚梦泓,夏勤 | Buy 买入 | ▼ | Outperform 增持 |
| 1 Jul 2022 | 国金证券 | 谢丽媛,贺虹萍 | Buy 买入 | ▼ | Outperform 增持 |
| 27 Mar 2020 | 西南证券 | 龚梦泓 | Outperform 增持 | ▲ | Buy 买入 |
| 28 Apr 2019 | 国元证券 | 邹翠利 | Buy 买入 | ▼ | Outperform 增持 |
| 2 May 2018 | 国元证券 | 邹翠利 | Outperform 增持 | ▲ | Buy 买入 |
| 20 Mar 2018 | 国元证券 | 邹翠利 | Buy 买入 | ▼ | Outperform 增持 |
Each broker's rating is compared with its previous report. 每家券商的评级与其上一份研报比较。
| Broker 券商 | Analyst 分析师 | Latest Rating 最新评级 | Date 日期 | Reports 研报 | Target 目标价 |
|---|---|---|---|---|---|
| 西南证券 | 龚梦泓,方建钊 | Outperform 增持 | 11 May 2026 | 1 | — |
| 山西证券 | 陈玉卢 | Buy 买入 | 28 Apr 2026 | 1 | — |
Each row is a broker's latest report in the last twelve months. A price target is given in 0 of 2 reports. 每行为该券商近十二个月的最新研报；2 份中 0 份给出目标价。
Each bar counts the brokers publishing on this company in a quarter. The latest quarter is not yet complete. 每根柱为该季度发布本公司研报的券商数，最近一个季度尚未结束。